Induced pluripotent stem cells-A new foundation in medicine

Journal of Experimental and Clinical Medicine

Volumn 2, Issue 5, 2010, Pages 202-217

  Huang, George T J ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Cancer iPS cells; Embryonic stem (ES) cells; Genome wide epigenetic profile; Global gene expression profile; Induced pluripotent stem (iPS) cells; Regenerative medicine; Tissue regeneration

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX2; VIRUS VECTOR;

BLOOD DISEASE; CANCER CELL; CELL DIFFERENTIATION; CELL FATE; CELL IMMORTALIZATION; CELL ISOLATION; CELL NUCLEUS TRANSPLANTATION; CELL REGENERATION; CELL STRUCTURE; CELL THERAPY; DNA TRANSPOSITION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; EPIGENETICS; FIBROBLAST; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC DISORDER; HEMATOPOIETIC STEM CELL; HUMAN; KERATINOCYTE; LIVER CELL; MOLECULAR CLONING; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PLURIPOTENT STEM CELL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOMATIC CELL; STOCHASTIC MODEL; TELOMERE; TETRAPLOIDY; TISSUE REGENERATION;

EID: 77958188802     PISSN: 18783317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1878-3317(10)60033-2     Document Type: Review

References (109)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
2. Takahashi K, Yamanaka S Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
3. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
4. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
5. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, Cowling R, et al. piggyBac transposition reprograms fibro-blasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
6. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
7. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324:797-801.
8. Gonzalez F, Barragan Monasterio M, Tiscornia G, Montserrat Pulido N, Vassena R, Batlle Morera L, Rodriguez Piza I, et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci USA 2009, 106:8918-8922.
9. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.
10. Kim D, Kim C-H, Moon J-I, Chung Y-G, Chang M-Y, Han B-S, Ko S, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
11. Yakubov E, Rechavi G, Rozenblatt S, Givol D Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Comm 2010, 394:189-193.
12. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008, 3:568-574.
13. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008, 2:525-528.
14. Lyssiotis CA, Foreman RK, Staerk J, Garcia M, Mathur D, Markoulaki S, Hanna J, et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 2009, 106:8912-8917.
15. Ichida JK, Blanchard J, Lam K, Son EY, Chung JE, Egli D, Loh KM, et al. A small-molecule inhibitor of Tgf-[beta] signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 2009, 5:491-503.
16. Martin GR Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981, 78:7634-7638.
17. Evans MJ, Kaufman MH Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
18. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
19. Stadtfeld M, Brennand K, Hochedlinger K Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 2008, 18:890-894.
20. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton Menno P, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008, 133:250-264.
21. Kim JB, Sebastiano V, Wu G, Araúzo-Bravo MJ, Sasse P, Gentile L, Ko K, et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009, 136:411-419.
22. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Arauzo-Bravo MJ, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008, 454:646-650.
23. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K Induced pluripotent stem cells generated without viral integration. Science 2008, 322:945-949.
24. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008, 321:699-702.
25. Kunisato A, Wakatsuki M, Kodama Y, Shinba H, Ishida I, Nagao K Generation of induced pluripotent stem (iPS) cells by efficient reprogramming of adult bone marrow cells. Stem Cells Dev 2010, 19:229-238.
26. Tsai S-Y, Clavel C, Kim S, Ang Y-S, Grisanti L, Lee D-F, Kelley K, et al. Oct4 and Klf4 reprogram dermal papilla cells into induced pluripotent stem cells. Stem Cells 2010, 28:221-228.
27. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, et al. Generation of induced pluripotent stem cells from human blood. Blood 2009, 113:5476-5479.
28. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
29. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotech 2008, 26:101-106.
30. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotech 2008, 26:1276-1284.
31. Li C, Zhou J, Shi G, Ma Y, Yang Y, Gu J, Yu H, et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 2009, 18:4340-4349.
32. Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodríguez-Pizà I, Vassena R, Raya A, et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2 2009, 5:353-357.
33. Giorgetti A, Montserrat N, Rodriguez-Piza I, Azqueta C, Veiga A, Belmonte JCI Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat Protocols 2010, 5:811-820.
34. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009, 106:15720-15725.
35. Yan X, Qin H, Qu C, Tuan RS, Shi S, Huang GT-J iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev 2010, 19:469-480.
36. Miyoshi K, Tsuji D, Kudoh K, Satomura K, Muto T, Itoh K, Noma T Generation of human induced pluripotent stem cells from oral mucosa. J Biosci Bioeng 2010, 110:345-350.
37. Kim JB, Greber B, Arauzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Scholer HR Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
38. Kang L, Wang J, Zhang Y, Kou Z, Gao S iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009, 5:135-138.
39. Zhao X-Y, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009, 461:86-90.
40. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, Kupriyanov S, et al. Adult mice generated from induced pluripotent stem cells. Nature 2009, 461:91-94.
41. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
42. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010, 28:848-855.
43. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009, 5:111-123.
44. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009, 41:1350-1353.
45. Surani MA Reprogramming of genome function through epi-genetic inheritance. Nature 2001, 414:122-128.
46. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
47. Thuan NV, Kishigami S, Wakayama T How to improve the success rate of mouse cloning technology. J Reprod Dev 2010, 56:20-30.
48. Oh HJ, Hong SG, Park JE, Kang JT, Kim MJ, Kim MK, Kang SK, et al. Improved efficiency of canine nucleus transfer using roscovitine-treated canine fibroblasts. Theriogenology 2009, 72:461-470.
49. Gómez MC, Pope CE, Dresser BL Nuclear transfer in cats and its application. Theriogenology 2006, 66:72-81.
50. Miyashita N, Shiga K, Yonai M, Kaneyama K, Kobayashi S, Kojima T, Goto Y, et al. Remarkable differences in telomere lengths among cloned cattle derived from different cell types. Biol Reprod 2002, 66:1649-1655.
51. Yu J, Vodyanik MA, He P, Slukvin II, Thomson JA Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 2006, 24:168-176.
52. Cowan CA, Atienza J, Melton DA, Eggan K Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309:1369-1373.
53. Revazova ES, Turovets NA, Kochetkova OD, Kindarova LB, Kuzmichev LN, Janus JD, Pryzhkova MV Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2007, 9:432-449.
54. Revazova ES, Turovets NA, Kochetkova OD, Agapova LS, Sebastian JL, Pryzhkova MV, Smolnikova VI, et al. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2008, 10:11-24.
55. Matsui Y, Zsebo K, Hogan BL Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992, 70:841-847.
56. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
57. Kanatsu-Shinohara M, Inoue K, Lee J, Yoshimoto M, Ogonuki N, Miki H, Baba S, et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 2004, 119:1001-1012.
58. Do JT, Schöler HR Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 2004, 22:941-949.
59. Yamanaka S Elite and stochastic models for induced pluripotent stem cell generation. Nature 2009, 460:49-52.
60. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 2009, 27:1033-1037.
61. Smith KP, Luong MX, Stein GS Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol 2009, 220:21-29.
62. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009, 27:543-549.
63. Okita K, Ichisaka T, Yamanaka S Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
64. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 2001, 11:1553-1558.
65. Sumer H, Jones KL, Liu J, Heffernan C, Tat PA, Upton KR, Verma PJ Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells. Stem Cells Dev 2010, 19:239-246.
66. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1:55-70.
67. Fulka J, Miyashita N, Nagai T, Ogura A Do cloned mammals skip a reprogramming step?. Nat Biotech 2004, 22:25-26.
68. Shiels PG, Kind AJ, Campbell KHS, Wilmut I, Waddington D, Colman A, Schnieke AE Analysis of telomere length in Dolly, a sheep derived by nuclear transfer. Cloning 1999, 1:119-125.
69. Shiels PG, Jardine AG Dolly, no longer the exception: telomeres and implications for transplantation. Cloning Stem Cells 2003, 5:157-160.
70. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4:141-154.
71. Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, Huo H, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 2010, 464:292-296.
72. Wernig M, Zhao J-P, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci 2008, 105:5856-5861.
73. Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev 2010, 19:1017-1023.
74. Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010, 107:4335-4340.
75. Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lindgren A, Conway AE, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009, 27:806-811.
76. Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, Thomson J, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009, 27:559-567.
77. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, et al. Hemangioblastic derivatives from human induced pluripo-tent stem cells exhibit limited expansion and early senescence. Stem Cells 2010, 28:704-712.
78. Chang K-H, Huang A, Hirata RK, Wang P-R, Russell DW, Papayannopoulou T Globin phenotype of erythroid cells derived from human induced pluripotent stem cells. Blood 2010, 115:2553-2554.
79. Kulkeaw K, Horio Y, Mizuochi C, Ogawa M, Sugiyama D Variation in hematopoietic potential of induced pluripotent stem cell lines. Stem Cell Rev 2010, 6:381-389.
80. Mizuno Y, Chang H, Umeda K, Niwa A, Iwasa T, Awaya T, Fukada S, et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 2010, 24:2245-2253.
81. Gallicano GI, Mishra L Hepatocytes from induced pluripotent stem cells: a giant leap forward for hepatology. Hepatology 2010, 51:20-22.
82. Sullivan GJ, Hay DC, Park I-H, Fletcher J, Hannoun Z, Payne CM, Dalgetty D, et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010, 51:329-335.
83. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010, 51:297-305.
84. Hanna J, Wernig M, Markoulaki S, Sun C-W, Meissner A, Cassady JP, Beard C, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318:1920-1923.
85. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009, 460:53-59.
86. Kolf C, Cho E, Tuan R Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007, 9:204.
87. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, Cho DJ, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007, 40:75-90.
88. Huang GT, Gronthos S, Shi S Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res 2009, 88:792-806.
89. de Peppo GM, Sjovall P, Lenneras M, Strehl R, Hyllner J, Thomsen P, Karlsson C Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A 2010 Aug 2, [Epub ahead of print].
90. Cohen S, Leshansky L, Zussman E, Burman M, Srouji S, Livne E, Abramov N, et al. Repair of full-thickness tendon injury using connective tissue progenitors efficiently derived from human embryonic stem cells and fetal tissues. Tissue Eng Part A 2010 Aug 28, [Epub ahead of print].
91. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 2003, 100:12741-12746.
92. Lengner CJ iPS cell technology in regenerative medicine. Ann N Y Acad Sci 2010, 1192:38-44.
93. Nishikawa S-I, Goldstein RA, Nierras CR The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008, 9:725-729.
94. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, et al. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
95. Miyoshi N, Ishii H, Nagai K, Hoshino H, Mimori K, Tanaka F, Nagano H, et al. Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA 2010, 107:40-45.
96. Carette JE, Pruszak J, Varadarajan M, Blomen VA, Gokhale S, Camargo FD, Wernig M, et al. Generation of iPSCs from cultured human malignant cells. Blood 2010, 115:4039-4042.
97. Solanki A, Lee KB A step closer to complete chemical reprogramming for generating iPS cells. Chembiochem 2010, 11:755-757.
98. Maherali N, Hochedlinger K Tgf[beta] signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol 2009, 19:1718-1723.
99. Yamanaka S A fresh look at iPS cells. Cell 2009, 137:13-17.
100. Sridharan R, Plath K Illuminating the black box of reprogramming. Cell Stem Cell 2008, 2:295-297.
101. Cobourne MT, Sharpe PT Tooth and jaw: molecular mechanisms of patterning in the first branchial arch. Arch Oral Biol 2003, 48:1-14.
102. Chai Y, Jiang X, Ito Y, Bringas P, Han J, Rowitch DH, Soriano P, et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000, 127:1671-1679.
103. Han J, Yuan P, Yang H, Zhang J, Soh BS, Li P, Lim SL, et al. Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 2010, 463:1096-1100.
104. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 2000, 97:13625-13630.
105. Huang GT, Shagramanova K, Chan SW Formation of odonto-blast-like cells from cultured human dental pulp cells on dentin in vitro. J Endod 2006, 32:1066-1073.
106. Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, Shi S SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 2003, 100:5807-5812.
107. Huang AH, Chen YK, Lin LM, Shieh TY, Chan AW Isolation and characterization of dental pulp stem cells from a supernumerary tooth. J Oral Pathol Med 2008, 37:571-574.
108. Kerkis I, Kerkis A, Dozortsev D, Stukart-Parsons GC, Gomes Massironi SM, Pereira LV, Caplan AI, et al. Isolation and characterization of a population of immature dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers. Cells Tissues Organs 2006, 184:105-116.
109. Scheper W, Copray S The molecular mechanism of induced pluripotency: a two-stage switch. Stem Cell Rev 2009, 5:204-223.